帕金森病与抑郁症：贝克抑郁量表的心理测量特性
Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory.
作者信息
Levin B E, Llabre M M, Weiner W J
机构信息
Department of Neurology, University of Miami, Florida.
出版信息
J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1401-4. doi: 10.1136/jnnp.51.11.1401.
Abstract
Although the Beck Depression Inventory (BDI) is one of the most frequently employed measures of depression in Parkinson's disease, the somatic items included in the scale raise questions about its ability to differentiate depression from manifestations of the disease. The internal consistency and validity of the BDI as a measure of depression in a sample of 119 Parkinson's disease patients and 76 controls were studied. Results from an item analysis suggested that depression in Parkinson's disease patients is not a somatic artifact. Internal consistency reliability within the Parkinson's disease group was high. The factorial validity of the BDI was confirmed in both Parkinson's disease and control subjects. The results also indicated that Parkinsonian symptoms of depression can be measured separately from symptoms of the disease. These data suggest that the BDI including the somatic items is a reliable and valid measure of depression in Parkinson's disease and control subjects.
摘要
尽管贝克抑郁量表（BDI）是帕金森病中最常用的抑郁测量工具之一，但该量表中的躯体项目引发了对其区分抑郁与疾病表现能力的质疑。对119名帕金森病患者和76名对照样本中BDI作为抑郁测量工具的内部一致性和有效性进行了研究。项目分析结果表明，帕金森病患者的抑郁并非躯体假象。帕金森病组内的内部一致性信度较高。BDI在帕金森病患者和对照受试者中均得到了因子效度的证实。结果还表明，帕金森病性抑郁症状可与疾病症状分开测量。这些数据表明，包含躯体项目的BDI是帕金森病患者和对照受试者中抑郁的可靠且有效的测量工具。
相似文献
1
Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory.帕金森病与抑郁症：贝克抑郁量表的心理测量特性
J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1401-4. doi: 10.1136/jnnp.51.11.1401.
2
[Physical symptoms of Parkinson's disease and the score on Beck's Depression Inventory].[帕金森病的身体症状与贝克抑郁量表得分]
Tijdschr Gerontol Geriatr. 1991 Aug;22(4):134-8.
3
Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson's disease.中文版贝克抑郁自评量表（BDI-II）在帕金森病中的心理计量学和诊断性能。
Neurol Sci. 2023 May;44(5):1607-1612. doi: 10.1007/s10072-023-06619-w. Epub 2023 Jan 18.
4
The Beck Depression Inventory as a screening device for major depression in renal dialysis patients.贝克抑郁量表作为肾透析患者重度抑郁的筛查工具。
Int J Psychiatry Med. 1988;18(4):365-74. doi: 10.2190/m1tx-v1ej-e43l-rklf.
5
Screen Fast, Screen Faster: A Pilot Study to Screen for Depressive Symptoms Using the Beck Depression Inventory Fast Screen in Parkinson's Disease With Mild Cognitive Impairment.更快筛查，更快行动：一项使用贝克抑郁量表快速筛查法对帕金森病伴轻度认知障碍患者进行抑郁症状筛查的试点研究。
Front Neurol. 2021 Mar 8;12:640137. doi: 10.3389/fneur.2021.640137. eCollection 2021.
6
Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects.帕金森病中的抑郁症状：与残疾对照受试者的比较。
J Geriatr Psychiatry Neurol. 1990 Jan-Mar;3(1):3-9. doi: 10.1177/089198879000300102.
7
On the validity of the Beck Depression Inventory. A review.关于贝克抑郁量表的效度：一篇综述
Psychopathology. 1998;31(3):160-8. doi: 10.1159/000066239.
8
Early Detection of Depression in Parkinson's Disease: Psychometrics and Diagnostics of the Spanish Version of the Beck Depression Inventory.帕金森病抑郁的早期检测：贝克抑郁量表西班牙语版的心理测量学与诊断学
Arch Clin Neuropsychol. 2024 May 21;39(4):418-422. doi: 10.1093/arclin/acad087.
9
Psychometric properties of the Beck Depression Inventory II (BDI-II) among community-dwelling older adults.社区居住的老年人中贝克抑郁量表第二版（BDI-II）的心理测量学特性。
Behav Modif. 2008 Jan;32(1):3-20. doi: 10.1177/0145445507303833.
10
Psychometric properties of the Beck Depression Inventory-II: a comprehensive review.贝克抑郁自评量表 II 的心理测量学特性：全面综述。
Braz J Psychiatry. 2013 Oct-Dec;35(4):416-31. doi: 10.1590/1516-4446-2012-1048. Epub 2013 Dec 23.
引用本文的文献
1
Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone.临床实践中抑郁症的治疗：曲唑酮多学科应用的新见解
Front Psychiatry. 2023 Aug 15;14:1207621. doi: 10.3389/fpsyt.2023.1207621. eCollection 2023.
2
Benefits of a 12-Week Non-Drug "Brain Fitness Program" for Patients with Attention-Deficit/Hyperactive Disorder, Post-Concussion Syndrome, or Memory Loss.针对患有注意力缺陷多动障碍、脑震荡后综合征或记忆力减退的患者，进行为期12周的非药物“大脑健身计划”的益处。
J Alzheimers Dis Rep. 2023 Jun 29;7(1):675-697. doi: 10.3233/ADR-220091. eCollection 2023.
3
Combined multidisciplinary in/outpatient rehabilitation delays definite nursing home admission in advanced Parkinson's disease patients.多学科联合门诊及住院康复可延缓晚期帕金森病患者入住养老院的时间。
Front Neurol. 2023 Apr 13;14:1128891. doi: 10.3389/fneur.2023.1128891. eCollection 2023.
4
The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease.GBA和LRRK2对帕金森病中情绪障碍的影响。
Mov Disord Clin Pract. 2023 Mar 21;10(4):606-616. doi: 10.1002/mdc3.13722. eCollection 2023 Apr.
5
Mood symptoms in cervical dystonia: Relationship with motor symptoms and quality of life.颈部肌张力障碍中的情绪症状：与运动症状及生活质量的关系。
Clin Park Relat Disord. 2023 Jan 31;8:100186. doi: 10.1016/j.prdoa.2023.100186. eCollection 2023.
6
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers.LRRK2和GBA突变携带者中异常的多巴胺转运体与功能连接模式。
NPJ Parkinsons Dis. 2022 Mar 3;8(1):20. doi: 10.1038/s41531-022-00285-z.
7
Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers-Study Protocol for a Multicentre, Randomized Controlled Trial.帕金森病患者及其家庭照顾者的预先护理计划与护理协调——一项多中心随机对照试验的研究方案
Front Neurol. 2021 Aug 5;12:673893. doi: 10.3389/fneur.2021.673893. eCollection 2021.
8
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.GBA 和 LRRK2 突变与炎症标志物的增加无关。
J Parkinsons Dis. 2021;11(3):1285-1296. doi: 10.3233/JPD-212624.
9
Impact of subthreshold depression on health-related quality of life in patients with Parkinson's disease based on cognitive status.基于认知状态的亚临床抑郁对帕金森病患者健康相关生活质量的影响。
Health Qual Life Outcomes. 2021 Mar 25;19(1):107. doi: 10.1186/s12955-021-01753-5.
10
Do Benzodiazepines Impair Motor and Nonmotor Symptoms in a Sample of Parkinson's Disease Patients?苯二氮䓬类药物是否会损害帕金森病患者样本中的运动和非运动症状？
Cureus. 2021 Feb 8;13(2):e13220. doi: 10.7759/cureus.13220.
本文引用的文献
1
An inventory for measuring depression.一份用于测量抑郁的量表。
Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004.
2
Depression, intellectual impairment, and Parkinson disease.抑郁症、智力障碍与帕金森病。
Neurology. 1981 Jun;31(6):645-50. doi: 10.1212/wnl.31.6.645.
3
Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.帕金森病。偏侧性与痴呆及神经化学发现之间的可能关系。
Arch Neurol. 1984 Sep;41(9):935-41. doi: 10.1001/archneur.1984.04050200041016.
4
Movement disorders in the psychiatric patient.精神科患者的运动障碍
Hosp Community Psychiatry. 1984 Apr;35(4):377-83. doi: 10.1176/ps.35.4.377.
5
Psychiatric symptoms in Parkinsonism.帕金森病中的精神症状。
J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):188-91. doi: 10.1136/jnnp.33.2.188.
6
Psychiatric disturbances in Parkinson's disease.
Dis Nerv Syst. 1972 Sep;33(9):577-83.
7
Depressive symptoms in Parkinson patients referred for thalamotomy.
J Neurol Neurosurg Psychiatry. 1967 Aug;30(4):368-70. doi: 10.1136/jnnp.30.4.368.
8
Some psychological factors in Parkinsonism.帕金森病中的一些心理因素。
J Neurol Neurosurg Psychiatry. 1974 Jan;37(1):27-31. doi: 10.1136/jnnp.37.1.27.
9
Does levodopa alter depression and psychopathology in Parkinsonism patients?左旋多巴会改变帕金森病患者的抑郁和精神病理学状况吗？
J Neurol Neurosurg Psychiatry. 1973 Dec;36(6):925-35. doi: 10.1136/jnnp.36.6.925.
10
Levodopa and L-tryptophan therapy in Parkinsonism.
Lancet. 1972 Mar 25;1(7752):654-8. doi: 10.1016/s0140-6736(72)90461-8.
Zotero 插件